» Articles » PMID: 27422527

Anorectal Malignant Melanoma: Curative Abdominoperineal Resection: Patient Selection with 18F-FDG-PET/CT

Overview
Publisher Biomed Central
Date 2016 Jul 17
PMID 27422527
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anorectal malignant melanomas (ARMM) are rare tumors, characterized by an early lymphatic spread and distant metastasis, resulting in an extremely poor overall survival. The objective of this study was to determine the pattern of regional lymph node metastasis (LNM) by computed tomography (CT) and 18F-FDG-PET/CT in patients undergoing abdominoperineal resection (APR) and its impact on oncologic outcome.

Methods: A retrospective analysis of six consecutive patients who underwent APR due to primary ARMM was performed. Patients were staged by CT and PET/CT.

Results: Four out of six patients had preoperative LNM involvement (two patients inguinal and perirectal, one iliacal, one perirectal), with two of them presenting with distant metastases additionally. Inguinal/iliacal LNM in two patients as well as liver metastasis in one patient was seen in PET/CT and missed by CT. The three patients with initial inguinal/iliacal LNM died during the observation period (overall survival: 10 (6-18) months). The three patients without inguinal/iliacal LNM involvement are currently alive, one patient showing a slowly progressive disease since 5 years, and two patients are tumor-free since 8.5 and 1.5 years (the patients had initial perirectal LNM).

Conclusions: In ARMM, PET/CT is superior to CT in detection of LNM and distant metastasis. APR is possibly a curative approach if the PET/CT shows exclusively perirectal LNM despite locally advanced tumor growth.

Citing Articles

Anal melanoma: a clinical challenge without therapeutic consensus.

Fuentes-Calvo K, Alvarez-Bautista F, Santes O, De Nora-Jimenez R, Arias-Ruiz L, Salgado-Nesme N J Surg Case Rep. 2025; 2025(1):rjaf015.

PMID: 39845525 PMC: 11752850. DOI: 10.1093/jscr/rjaf015.


Evidence of 18 F-FDG Utility in Rare Case of Metastatic Anal Melanoma With Prolonged Survival.

Ranes J, Ormaza Vera A, Flynt L Clin Nucl Med. 2024; 50(3):257-260.

PMID: 39570051 PMC: 11801423. DOI: 10.1097/RLU.0000000000005551.


Anorectal Melanoma: A Rare Cause of Large Bowel Obstruction.

Dnyanmote A, Jadhav S, Vasava K, Immadi S Cureus. 2024; 16(3):e56128.

PMID: 38618462 PMC: 11015112. DOI: 10.7759/cureus.56128.


Early-Stage Primary Rectal Melanoma: A Case Report.

El Youssi Z, Mansouri H, Elouaouch S, Moukhlissi M, Berhili S, Mezouar L Cureus. 2023; 15(7):e42629.

PMID: 37641758 PMC: 10460638. DOI: 10.7759/cureus.42629.


Extensive resection improves overall and disease-specific survival in localized anorectal melanoma: A SEER-based study.

Liu C, Tang C, Zhang J, Zhu P Front Surg. 2022; 9:997169.

PMID: 36111221 PMC: 9468230. DOI: 10.3389/fsurg.2022.997169.


References
1.
Ballo M, Gershenwald J, Zagars G, Lee J, Mansfield P, Strom E . Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol. 2002; 20(23):4555-8. DOI: 10.1200/JCO.2002.03.002. View

2.
Stoidis C, Spyropoulos B, Misiakos E, Fountzilas C, Paraskeva P, Fotiadis C . Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report. World J Surg Oncol. 2009; 7:64. PMC: 2731760. DOI: 10.1186/1477-7819-7-64. View

3.
Caglar M, Yener C, Karabulut E . Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer. Int J Comput Assist Radiol Surg. 2014; 10(7):993-1002. DOI: 10.1007/s11548-014-1115-8. View

4.
Cagir B, Whiteford M, Topham A, Rakinic J, Fry R . Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999; 42(9):1203-8. DOI: 10.1007/BF02238576. View

5.
Pfannenberg C, Schwenzer N . [Whole-body staging of malignant melanoma: advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI]. Radiologe. 2015; 55(2):120-6. DOI: 10.1007/s00117-014-2762-z. View